April 17, 2026
The first dedicated RCT of stellate ganglion block for Long COVID POTS launched in 2026. Here's everything that's changed: the STAR-CO trial protocol, the Frontiers in Neuroscience editorial endorsement, new mechanistic data on catecholamine-driven mitochondrial uncoupling, and the updated clinical protocol for autonomic reset.











